Lixte Biotechnology Holdings, Inc. (LIXT) Earnings History
Net Loss21 years of earnings data (2005–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Lixte Biotechnology Holdings, Inc. (LIXT) Earnings Overview
As of June 28, 2026, Lixte Biotechnology Holdings, Inc. (LIXT) reported trailing twelve-month net income of -$7M, reflecting +20.8% year-over-year growth. The company earned $-0.67 per diluted share over the past four quarters.
Looking at the long-term picture, LIXT's historical earnings data spans multiple years. The company achieved its highest annual net income of -$3,579 in fiscal 2012.
Lixte Biotechnology Holdings, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ONCY (-$35M net income), CASI (-$49M net income, -137.6% margin), NKTR (-$158M net income, -297.1% margin), LIXT has comparable earnings metrics. Compare LIXT vs ONCY →
LIXT Earnings vs Peers
Earnings metrics vs comparable public companies
LIXT Historical Earnings Data (2005–2025)
21 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$6M | -67.6% | -$5M | $-1.26 | - | - |
| 2024 | -$4M | +29.5% | -$4M | $-1.59 | - | - |
| 2023 | -$5M | +19.4% | -$5M | $-2.66 | - | - |
| 2022 | -$6M | +6.2% | -$6M | $-4.00 | - | - |
| 2021 | -$7M | -106.1% | -$7M | $-5.00 | - | - |
| 2020 | -$3M | -33.8% | -$3M | $-2.89 | - | - |
| 2019 | -$2M | -14.4% | -$2M | $-2.20 | - | - |
| 2018 | -$2M | -18.0% | -$2M | $-2.18 | - | - |
| 2017 | -$2M | +15.3% | -$2M | $-1.94 | - | - |
| 2016 | -$2M | +25.1% | -$2M | $-2.68 | - | - |
| 2015 | -$3M | -3.1% | -$3M | $-3.66 | -1426.0% | -1323.0% |
| 2014 | -$3M | -101.2% | -$2M | $-3.74 | - | - |
| 2013 | -$1M | -38318.6% | -$1M | $-1.98 | - | - |
| 2012 | $-3,579 | +99.8% | -$2M | $-5.51 | - | - |
| 2011 | -$2M | -135.0% | -$2M | $-0.00 | - | - |
| 2010 | $-880,000 | +43.3% | $-882,000 | $-0.00 | - | - |
| 2009 | -$2M | -22.0% | -$2M | $-0.00 | - | - |
| 2008 | -$1M | +22.8% | -$1M | $-0.00 | - | - |
| 2007 | -$2M | -237.6% | -$2M | $-0.00 | - | - |
| 2006 | $-488,084 | -1384.9% | $-449,982 | $-0.00 | - | - |
| 2005 | $-32,869 | - | $-32,869 | $-0.00 | - | - |
Download Data
Export LIXT earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
21+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
LIXT — Frequently Asked Questions
Quick answers to the most common questions about buying LIXT stock.
What is LIXT earnings per share (EPS)?
LIXT trailing twelve-month (TTM) diluted EPS is $-0.67, reflecting +20.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2005 to 2025 is available in the table on this page.
What is Lixte Biotechnology Holdings, Inc.'s net income?
Lixte Biotechnology Holdings, Inc. (LIXT) trailing twelve-month net income is $-7M as of 2025. Earnings grew +20.8% year-over-year.
Is LIXT profitable?
LIXT is not currently profitable on a TTM basis, reporting a net loss of $-7M. Net margin is N/A. Investors should monitor for a return to profitability.
What is LIXT's earnings growth rate?
LIXT compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2005 to 2025.
What are LIXT's profit margins?
Lixte Biotechnology Holdings, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -102.0%.
Is LIXT growing earnings?
Yes, LIXT earnings are accelerating — EPS growth of +20.8% exceeds the 5-year CAGR of N/A. TTM net income reached $-7M. Earnings momentum is strengthening.
What was LIXT's best earnings year?
Lixte Biotechnology Holdings, Inc.'s highest annual net income on record is $-3579.00, achieved in fiscal year 2012. Earnings history on this page spans 2005 to 2025 and includes all annual and quarterly figures.
What were LIXT's earnings last quarter?
LIXT's most recent reported quarter was Q1 2026. Net income was $-2M with diluted EPS of $-0.18. For a full breakdown of all quarters, see the quarterly earnings table on this page.